Concepedia

H. Bruce Diaz

HB

Statistics

Publications

5

Citations

691

H-Index

5

Active since

2000

Affiliations

Eli Lilly (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

H. Bruce Diaz is an author at Eli Lilly (United States) specializing in cell biology, life sciences, and pharmacology.

Publications per year

2000–2015

5

Publications

5

PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation

Jill K. Slack‐Davis, Scott T. Eblen, Maja Zečević et al. · The Journal of Cell Biology · 2003 · 276 citations · Full text

, , +17

LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms

Constance King, H. Bruce Diaz, Samuel McNeely et al. · Molecular Cancer Therapeutics · 2015 · 189 citations · Full text

, , +17

Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak

Huaiyu Sun, Alastair J. King, H. Bruce Diaz et al. · Current Biology · 2000 · 141 citations · Full text

, , +14

Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer

Emiliano Calvo, Victor J. Chen, Mark S. Marshall et al. · Investigational New Drugs · 2014 · 57 citations

, , +7

LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models

Darlene Barnard, H. Bruce Diaz, Teresa F. Burke et al. · Investigational New Drugs · 2015 · 28 citations

, , +12

1–5 of 5